Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2006-11-17 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VALENCE-EN-POITOU (86700), Vienne
SELARL PHARMACIE DU BOURG : revenue, balance sheet and financial ratios
SELARL PHARMACIE DU BOURG is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VALENCE-EN-POITOU (86700),
this company of category PME
shows in 2022 a revenue of 1.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DU BOURG (SIREN 492914544)
Indicator
2023
2022
2021
2017
2016
2015
2014
Revenue
N/C
1 729 364 €
N/C
1 583 438 €
1 745 653 €
1 681 723 €
1 703 699 €
Net income
48 057 €
133 776 €
106 964 €
62 466 €
103 765 €
94 311 €
44 513 €
EBITDA
N/C
79 875 €
N/C
18 136 €
69 486 €
52 226 €
24 016 €
Net margin
N/C
7.7%
N/C
3.9%
5.9%
5.6%
2.6%
Revenue and income statement
In 2023, SELARL PHARMACIE DU BOURG generates positive net income of 48 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2014-2023: 45 k€ -> 48 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
48 057 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 50%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
49.651%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
61.111%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DU BOURG
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2017
2021
2022
2023
Debt ratio
142.667
162.101
135.991
113.606
66.754
54.801
49.651
Financial autonomy
38.365
35.587
39.428
42.958
54.505
58.893
61.111
Repayment capacity
23.298
14.641
11.637
16.36
None
5.437
None
Cash flow / Revenue
2.505%
5.211%
5.996%
4.2%
None%
7.754%
None%
Sector positioning
Debt ratio
49.652023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good
In 2023, the debt ratio of SELARL PHARMACIE DU BOURG (49.65) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
61.11%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good
In 2023, the financial autonomy of SELARL PHARMACIE DU BOURG (61.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
5.44 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELARL PHARMACIE DU BOURG (5.44) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 167.82. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
167.819
Liquidity indicators evolution SELARL PHARMACIE DU BOURG
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2014
2015
2016
2017
2021
2022
2023
Liquidity ratio
293.588
186.737
194.783
153.222
166.862
180.677
167.819
Interest coverage
122.189
60.765
43.996
150.711
None
7.574
None
Sector positioning
Liquidity ratio
167.822023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Average
In 2023, the liquidity ratio of SELARL PHARMACIE DU BOURG (167.82) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
7.57x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Excellent
In 2022, the interest coverage of SELARL PHARMACIE DU BOURG (7.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 189 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 741 days. Excellent situation: suppliers finance 552 days of the operating cycle (retail model).
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
189 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
741 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DU BOURG
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2017
2021
2022
2023
Operating WCR
241 891 €
204 111 €
196 945 €
189 316 €
0 €
150 541 €
0 €
Inventory turnover (days)
34
35
32
34
0
32
0
Customer payment term (days)
10
8
6
6
97
6
189
Supplier payment term (days)
25
33
35
41
791
39
741
Positioning of SELARL PHARMACIE DU BOURG in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELARL PHARMACIE DU BOURG is estimated at
567 047 €
(range 344 848€ - 797 141€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
344k€567k€797k€
567 047 €Range: 344 848€ - 797 141€
NAF 5 année 2023
Valuation method used
Net Income Multiple
48 057 €
×
11.8x
=567 047 €
Range: 344 849€ - 797 141€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DU BOURG with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DU BOURG
What is the revenue of SELARL PHARMACIE DU BOURG ?
The revenue of SELARL PHARMACIE DU BOURG in 2022 is 1.7 M€.
Is SELARL PHARMACIE DU BOURG profitable?
Yes, SELARL PHARMACIE DU BOURG generated a net profit of 48 k€ in 2023.
Where is the headquarters of SELARL PHARMACIE DU BOURG ?
The headquarters of SELARL PHARMACIE DU BOURG is located in VALENCE-EN-POITOU (86700), in the department Vienne.
Where to find the tax return of SELARL PHARMACIE DU BOURG ?
The tax return of SELARL PHARMACIE DU BOURG is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DU BOURG operate?
SELARL PHARMACIE DU BOURG operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart